CN1610743A - 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 - Google Patents

在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 Download PDF

Info

Publication number
CN1610743A
CN1610743A CNA018178049A CN01817804A CN1610743A CN 1610743 A CN1610743 A CN 1610743A CN A018178049 A CNA018178049 A CN A018178049A CN 01817804 A CN01817804 A CN 01817804A CN 1610743 A CN1610743 A CN 1610743A
Authority
CN
China
Prior art keywords
seq
polypeptide
polynucleotide
sequence
coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018178049A
Other languages
English (en)
Chinese (zh)
Inventor
M·佐德尔
E·E·埃文斯
M·A·博雷罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of CN1610743A publication Critical patent/CN1610743A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CNA018178049A 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 Pending CN1610743A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19446300P 2000-04-04 2000-04-04
US60/194,463 2000-04-04

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN200910007590A Division CN101643732A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Publications (1)

Publication Number Publication Date
CN1610743A true CN1610743A (zh) 2005-04-27

Family

ID=22717696

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA018178049A Pending CN1610743A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽
CN200910007590A Pending CN101643732A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN200910007590A Pending CN101643732A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Country Status (10)

Country Link
US (3) US7268207B2 (https=)
EP (1) EP1272636B8 (https=)
JP (1) JP2004502408A (https=)
CN (2) CN1610743A (https=)
AT (1) ATE404669T1 (https=)
AU (2) AU5311901A (https=)
CA (1) CA2413211A1 (https=)
DE (1) DE60135315D1 (https=)
NZ (1) NZ522282A (https=)
WO (1) WO2001074859A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102639555A (zh) * 2009-09-24 2012-08-15 加利福尼亚大学董事会 膀胱癌特异性配体肽

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7268207B2 (en) * 2000-04-04 2007-09-11 University Of Rochester Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
US7135278B1 (en) 2000-09-29 2006-11-14 University Of Rochester Method of screening for therapeutics for infectious diseases
JP2005503118A (ja) * 2001-02-14 2005-02-03 ジェンザイム・コーポレーション 改変ペプチドリガンド
WO2003004989A2 (en) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2003104428A2 (en) * 2002-01-21 2003-12-18 Vaccinex, Inc. Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
WO2004087058A2 (en) * 2003-03-28 2004-10-14 Vaccinex, Inc. Targeted mhc class i alpha3 vaccine delivery systems
US20050042218A1 (en) * 2003-07-10 2005-02-24 Vaccinex, Inc. MHC class I - peptide-antibody conjugates with modified beta2-microglobulin
CA2548180C (en) * 2003-12-04 2014-02-04 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
US20050266425A1 (en) * 2003-12-31 2005-12-01 Vaccinex, Inc. Methods for producing and identifying multispecific antibodies
EP1756308A1 (en) * 2004-04-23 2007-02-28 Exagen Diagnostics, Inc. Compositions and methods for breast cancer prognosis
CA2656918A1 (en) * 2006-06-22 2007-12-27 Vaccinex, Inc. Anti-c35 antibodies for treating cancer
JP5357782B2 (ja) * 2007-02-21 2013-12-04 バクシネックス インコーポレーティッド 抗原負荷ＣＤ１ｄ分子によるＮＫＴ細胞活性の調節
KR101666228B1 (ko) 2007-09-28 2016-10-13 인트렉손 코포레이션 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
NZ586544A (en) 2007-12-26 2012-07-27 Vaccinex Inc Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods
DK2385980T3 (en) 2009-01-08 2018-07-30 Albert Einstein College Medicine Inc BACTERIA VACCINES WITH CELL-WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND APPLICATIONS THEREOF
CA2794577C (en) * 2009-04-01 2021-02-23 The University Of British Columbia Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
RU2729116C2 (ru) * 2015-12-16 2020-08-04 Гритстоун Онколоджи, Инк. Идентификация, производство и применение неоантигенов
JP7763588B2 (ja) * 2017-09-05 2025-11-04 グリットストーン バイオ インコーポレイテッド Ｔ細胞療法用の新生抗原の特定法
KR20260039788A (ko) 2017-10-10 2026-03-20 시애틀 프로젝트 코포레이션 핫스팟을 이용한 신생항원 동정
CA3083097A1 (en) 2017-11-22 2019-05-31 Gritstone Oncology, Inc. Reducing junction epitope presentation for neoantigens
KR20250162921A (ko) 2018-04-09 2025-11-19 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 계내 유전자 시퀀싱의 방법
KR102318018B1 (ko) 2019-07-05 2021-10-28 한국생산기술연구원 마이크로 제품 제작용 맨드렐 제작 방법, 마이크로 제품 제작용 몰드 제작 방법 및 마이크로 제품 제작용 몰드
WO2021076770A1 (en) * 2019-10-18 2021-04-22 The Board Of Trustees Of The Leland Stanford Junior University Clinical- and industrial-scale intact-tissue sequencing
CN115407064B (zh) * 2021-05-26 2025-09-23 复旦大学附属肿瘤医院 肿瘤干细胞血管拟态标志物tem8在制备诊断试剂和试剂盒中的用途
US20240409582A1 (en) * 2022-08-23 2024-12-12 The University of North Texas Health Sciences Cente Design and characterization of inhibitory peptides (ipeps) derived from of mien 1 protein sequence

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0581600A (ja) * 1991-04-18 1993-04-02 Fujitsu Ltd 双曲線航法システムにおけるシステム監視処理方式
AU4998993A (en) 1992-08-07 1994-03-03 Epimmune, Inc. Hla binding peptides and their uses
CN1118572A (zh) 1993-03-05 1996-03-13 萨依特尔有限公司 Hla-a2.1组合肽及其用途
US5856131A (en) * 1997-02-24 1999-01-05 Incyte Pharmaceuticals, Inc. Human selenoprotein
US7026447B2 (en) * 1997-10-09 2006-04-11 Human Genome Sciences, Inc. 53 human secreted proteins
CA2316397A1 (en) * 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1999037775A2 (en) 1998-01-26 1999-07-29 Genquest, Inc. Compositions and methods for detecting and treating breast cancer
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2001040269A2 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US7268207B2 (en) * 2000-04-04 2007-09-11 University Of Rochester Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
US20030166277A1 (en) 2000-04-12 2003-09-04 University Of Rochester Targeted vaccine delivery systems
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
EP1340088B1 (en) * 2000-11-17 2007-01-17 University Of Rochester In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
WO2003104428A2 (en) * 2002-01-21 2003-12-18 Vaccinex, Inc. Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US20050042218A1 (en) 2003-07-10 2005-02-24 Vaccinex, Inc. MHC class I - peptide-antibody conjugates with modified beta2-microglobulin
CA2548180C (en) * 2003-12-04 2014-02-04 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102639555A (zh) * 2009-09-24 2012-08-15 加利福尼亚大学董事会 膀胱癌特异性配体肽
US8946379B2 (en) 2009-09-24 2015-02-03 The Regents Of The University Of California Bladder cancer specific ligand peptides
CN102639555B (zh) * 2009-09-24 2015-11-25 加利福尼亚大学董事会 膀胱癌特异性配体肽
US9539340B2 (en) 2009-09-24 2017-01-10 The Regents Of The University Of California Bladder cancer specific ligand peptides
US10335365B2 (en) 2009-09-24 2019-07-02 The Regents ot the Univershy of California Bladder cancer specific ligand peptides

Also Published As

Publication number Publication date
AU2001253119B2 (en) 2006-04-13
DE60135315D1 (de) 2008-09-25
NZ522282A (en) 2005-03-24
ATE404669T1 (de) 2008-08-15
JP2004502408A (ja) 2004-01-29
EP1272636B8 (en) 2008-10-08
US20090312263A1 (en) 2009-12-17
CN101643732A (zh) 2010-02-10
EP1272636B1 (en) 2008-08-13
US7910551B2 (en) 2011-03-22
CA2413211A1 (en) 2001-10-11
WO2001074859A3 (en) 2002-03-28
US20070081942A1 (en) 2007-04-12
US7268207B2 (en) 2007-09-11
AU5311901A (en) 2001-10-15
US20020155447A1 (en) 2002-10-24
WO2001074859A2 (en) 2001-10-11
EP1272636A2 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
CN1610743A (zh) 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽
CN1684700A (zh) 在乳腺癌和膀胱癌中差异表达的基因及编码多肽
CN1163509C (zh) 刺激神经和肾生长的RET配体(RetL)
JP4234319B2 (ja) 前立腺腫瘍ポリヌクレオチドおよび抗原組成物
AU2001253119A2 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
CN1813188A (zh) 癌的诊断
CN1505526A (zh) 用于wt1特异性免疫疗法的组合物和方法
CN1714150A (zh) 肿瘤内差异表达的基因产物及其应用
CN1297566C (zh) 编码新rg1多肽的dna
JP4211966B2 (ja) 免疫関連疾患を治療するための組成物及び方法
CN1289670C (zh) 用于调节癌细胞增生的多核苷酸
CN101039956A (zh) 细胞表面糖蛋白
CN1194012C (zh) 精子生成相关蛋白、其编码序列及用途
CN101173285A (zh) 在乳腺癌和膀胱癌中差异表达的基因及编码多肽
AU2006202984B2 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
CN100340574C (zh) 肿瘤标志物及其用途
EP1788085A1 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
CN1169956C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1304568C (zh) 新型人补体C1r样丝氨酸蛋白酶类似物,其编码序列及用途
CN1270633A (zh) 人氯离子通道zsig44
HK1065334B (en) Polynucleotide useful for modulating cancer cell proliferation
HK1107104A (en) Cell surface glycoprotein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20050427